Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2018
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsJulia A Sung, Shabnum Patel, Matthew L Clohosey, et al.
The Journal of Infectious Diseases|November 20, 2020
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral TherapyShane D Falcinelli, Kayla W Kilpatrick, Jenna Read, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
Journal of Virology|October 16, 2023
HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in womenKirston Barton, James M Ferguson, Ira W Deveson, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Correction for Van Gulck et al., "A truncated HIV Tat demonstrates potent and specific latency reversal activity"Ellen Van Gulck, Marion Pardons, Erik Nijs, et al.
Journal of Virology|August 21, 2020
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus MacaquesAmir Dashti, Chevaughn Waller, Maud Mavigner, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
The Journal of Clinical Investigation|December 23, 2025
Single cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypesJackson J Peterson, Shipra Chandel, Katherine James, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2018
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsJulia A Sung, Shabnum Patel, Matthew L Clohosey, et al.
The Journal of Infectious Diseases|November 20, 2020
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral TherapyShane D Falcinelli, Kayla W Kilpatrick, Jenna Read, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
Journal of Virology|October 16, 2023
HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in womenKirston Barton, James M Ferguson, Ira W Deveson, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Correction for Van Gulck et al., "A truncated HIV Tat demonstrates potent and specific latency reversal activity"Ellen Van Gulck, Marion Pardons, Erik Nijs, et al.
Journal of Virology|August 21, 2020
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus MacaquesAmir Dashti, Chevaughn Waller, Maud Mavigner, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
The Journal of Clinical Investigation|December 23, 2025
Single cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypesJackson J Peterson, Shipra Chandel, Katherine James, et al.
Pageof 22